Wonder if Dr. Yo was in on a date of such a liquidation

New Post Public Reply Private Reply Replies (2) Message Board
Goosebumps
766
Wonder if Dr. Yo was in on a date of such a liquidation sale. Maybe it’s October 29th? If they actually had a chance to win…lol… can’t ever dismiss the group of lies and mistruths. They might be approaching 10% of the vote soon with all the illegal mailing both email and snail mail without filing with the SEC.

How can you trust a group like this that doesn’t even follow the SEC laws? They are a screw up group and don’t have a clue how to run a company. They have no prior success stories and expect us to give them a chance in our biotech when they have absolutely no experience in a biotech. They haven’t shown us any reason they can or should run a biotech. It’s really the biggest gamble we have going… are you a gambler?

If you listened to Nader’s last webcast he said we have de-risked CYDY and have low risk to high return now. If we were to risk liquidation and bankruptcy from the 13d group that would be something. Who is foolish enough to risk this chance at dissolving the company in bankruptcy and the big money drops out all at one time before the hammer falls on us all. They get their money and swoop in and get Leronlimab for nothing… is this the real plan?

Who feels the trust is there with a group that lives on making up lies and bashes the management for the past couple of years. Then decides to try to steal the prize away from all of us? Is there someone foolish enough to see that they are not good for us? That they don’t have the interest of the stockholders and don’t care. They think a bashing campaign is enough to turn your vote. They don’t even need a plan of how they could run a company. Isn’t this just beyond unreal to me. How do you get followers based on hate and misinformation? Where has our values as Americans went when bashing is more real than the truth?

Can you really follow a group based on lies and mistruths? Do you understand the differences? Do you do research and not see the problem with the 13d group? Will you cut off your nose to spite your face because someone on a chat believes the 13d is better than Nader? Take Nader out of the picture because he really is right now.

Do you realize our first EUA or equivalent is coming from Brazil? Well it is… who is filing this EUA? It’s not Cytodyn it’s Biomm… they know the procedure and can nail it first time. We have a good thing going right now with this partnership. It’s all but just a short amount of time before we know interim results. Do you know what we expect from the interim results? We expect Canada and the UK to accept interim results… why? Because they stated at the end of the CD-12 trial they would accept a little more results even if they were interim results. We have missles on lock and loaded and just waiting for the right moment to pull the trigger and get Biomm working their butt off filing the proper papers to get that EUA.

Then do we sit back and gloat? Nope… we watch other countries around the world accept our results and order Leronlimab and before you know it we can’t make enough of Leronlimab. A tough problem to have.

Then we experience a huge growth period and Nader steps down since he achieved what he wanted to and just becomes a board member and former legend of Leronlimab. To over see a huge growth period by a real pharmaceutical CEO that knows how to build a company.

Or you can rush it all and vote for the 13d group that could have liquidation sale and you get nothing for your stock because they drive the price into the ground to steal Leronlimab out from under us…

This is only my opinion but I believe that the 13d group is not worth the risk. We have this without their risky potential to sell us for pennies.

Just so you know… I will state these same comments each week until we get the current management and BOD re-elected. I bet your shocked I would do that… naw by now you know I would. It’s just who I am and I want everyone to get rich of this investment… everyone but the 13d group that is… screw them bastards!!!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 5

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Costco's Core Comps Show Signs of Cooling but Trends Remain Strong

Updated Category News Views 210

Overview of Recent Sales Trends at Costco Costco Wholesale Corp. (NASDAQ: COST) is currently under the spotlight as its November U.S. core sales reportedly fell short of expectations, hinting at a rare slowing of the company’s ongoing momentum. This dip arrives at a crucial time as consumers gear up for the holiday season, bringing fresh debates regarding overall...

Continue Reading
Ember Partners to Create Unique Luxury Co-Ownership at Lake Powell

Updated Category News Views 115

New Partnership for Luxury Co-Ownership A new era of luxury vacation experiences is upon us as Ember joins with Ascend at Lake Powell to redefine property management and ownership. This collaboration brings forth not just a vacation property but a lifestyle choice that caters to the adventurers at heart. This emerging resort townhome community invites residents to...

Continue Reading
New Competing Offer for Religare's Stake Creates Tensions

Updated Category News Views 254

New Developments in Religare's Ownership Battle In a surprising turn of events, India's Religare Enterprises (NSE: RELG) has announced that a U.S. businessman has stepped into the fray with a proposal to secure a 26% stake. This development adds yet another layer of complexity to the ongoing struggle for control over the financial services company, especially following...

Continue Reading
Exploring the Impressive Growth of Insulet Stock Over 15 Years

Updated Category News Views 156

Insulet's Market Performance Insulet (NASDAQ: PODD) has emerged as a standout performer in the stock market arena over the past 15 years. With an annualized return of 23.21%, Insulet has outpaced the broader market by an astonishing 10.41%. Today, the company boasts a market capitalization of approximately $22.62 billion, a testament to its rapid growth and investor...

Continue Reading
UTSA and UT Health San Antonio Join Forces for Better Impact

Updated Category News Views 305

UTSA and UT Health San Antonio Merger Overview In a significant step for higher education, UTSA and The University of Texas Health Science Center at San Antonio have merged, resulting in the formation of The University of Texas at San Antonio (UT San Antonio). This new institution emerges as the third-largest public research university in Texas, following prestigious...

Continue Reading